Profile data is unavailable for this security.
About the company
Tissue Repair Limited is an Australia-based Phase 3 advanced biotechnology company developing second generation wound healing agents. The Company's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The Company is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.
- Revenue in AUD (TTM)548.09k
- Net income in AUD-4.14m
- Incorporated2012
- Employees--
- LocationTissue Repair LtdLevel 10, 255 Pitt StSYDNEY 2000AustraliaAUS
- Websitehttps://tissuerepair.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patrys Ltd | 1.39m | -3.54m | 8.23m | 15.00 | -- | 2.37 | -- | 5.90 | -0.0017 | -0.0017 | 0.0007 | 0.0017 | 0.2386 | -- | 0.6665 | -- | -60.57 | -52.81 | -68.65 | -56.79 | -- | -- | -253.86 | -249.64 | -- | -- | 0.00 | -- | -51.11 | 10.55 | 49.88 | -- | -4.41 | -- |
| Chimeric Therapeutics Ltd | 0.00 | -12.53m | 9.95m | -- | -- | 3.55 | -- | -- | -0.0136 | -0.0136 | 0.00 | 0.0028 | 0.00 | -- | -- | -- | -66.56 | -- | -194.88 | -- | -- | -- | -- | -- | -- | -58.48 | 0.5228 | -- | -- | -- | 51.65 | -- | -- | -- |
| Adalta Ltd | 1.78m | -5.38m | 11.37m | -- | -- | 5.28 | -- | 6.37 | -0.0111 | -0.0111 | 0.0036 | 0.0034 | 0.2682 | -- | 0.7681 | -- | -80.88 | -66.85 | -203.94 | -114.23 | -- | -- | -301.55 | -175.59 | -- | -51.02 | 0.5712 | -- | -49.47 | -13.04 | -10.93 | -- | -18.22 | -- |
| Algorae Pharmaceuticals Ltd | 125.20k | -2.10m | 11.81m | -- | -- | 3.92 | -- | 94.34 | -0.0013 | -0.0013 | 0.00008 | 0.0018 | 0.0338 | -- | 1.81 | -- | -56.60 | -47.73 | -61.85 | -54.26 | -- | -- | -1,673.77 | -865.45 | -- | -115.69 | 0.00 | -- | 197.95 | -30.46 | 0.5741 | -- | -- | -- |
| Invion Ltd | 3.74m | -5.63m | 13.63m | 8.00 | -- | 0.9149 | -- | 3.64 | -0.0009 | -0.0009 | 0.0006 | 0.0022 | 0.217 | -- | 2.65 | -- | -32.63 | -19.46 | -34.28 | -20.50 | -- | -- | -150.33 | -70.20 | -- | -- | 0.00 | -- | -9.54 | -0.7235 | -248.51 | -- | 171.96 | -- |
| Medlab Clinical Ltd | 366.64k | -3.94m | 15.23m | 14.00 | -- | -- | -- | 41.54 | -1.73 | -1.73 | 0.1606 | -0.3068 | 0.1069 | -- | 5.82 | -- | -103.72 | -55.07 | -240.52 | -69.75 | 84.77 | 52.86 | -970.74 | -335.43 | -- | -342.19 | -- | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
| BPH Energy Ltd | 843.69k | 4.56m | 15.82m | 2.00k | 3.38 | 0.5063 | -- | 18.75 | 0.0039 | 0.0039 | 0.0008 | 0.0257 | 0.0333 | -- | 11.41 | -- | 17.98 | 5.12 | 18.58 | 5.50 | -- | -- | 539.93 | 238.65 | -- | -- | 0.0029 | -- | 177.48 | 24.84 | 433.96 | -- | -- | -- |
| Alterity Therapeutics Ltd | 268.42k | -19.12m | 15.96m | 10.00 | -- | 1.14 | -- | 59.46 | -0.0052 | -0.0052 | 0.00007 | 0.0026 | 0.0115 | -- | 8.13 | 26,842.00 | -82.18 | -56.58 | -103.97 | -66.91 | -- | -- | -7,124.45 | -22,925.08 | -- | -- | 0.0114 | -- | 1,532.73 | 19.85 | -38.51 | -- | -4.01 | -- |
| Tissue Repair Ltd | 548.09k | -4.14m | 16.02m | -- | -- | 0.8883 | -- | 29.23 | -0.0684 | -0.0684 | 0.0091 | 0.2983 | 0.0262 | 0.00 | 1.22 | -- | -19.81 | -24.20 | -20.72 | -25.29 | 100.00 | -- | -755.00 | -10,570.14 | 14.34 | -- | 0.00 | -- | 4,842.86 | -- | 0.8698 | -- | -- | -- |
| BTC Health Ltd | 16.36k | 1.06m | 16.21m | 1.00 | 14.49 | 3.28 | 15.36 | 990.60 | 0.0035 | 0.0035 | 0.00005 | 0.0153 | 0.004 | -- | -- | -- | 26.09 | -21.22 | 27.32 | -22.60 | -- | -- | 6,450.37 | -3,306.65 | -- | -- | 0.00 | -- | 23.38 | -38.62 | 110.38 | -- | -- | -- |
| Biotron Ltd | 1.65m | -3.44m | 17.14m | 4.00 | -- | -- | -- | 10.42 | -0.0038 | -0.0038 | 0.0018 | -0.0003 | 0.7108 | -- | -- | -- | -148.49 | -77.12 | -234.15 | -92.61 | -120.34 | -127.14 | -208.89 | -238.85 | -- | -- | -- | -- | 14.94 | 8.93 | 1.61 | -- | -- | -- |
| Island Pharmaceuticals Ltd | 4.72k | -2.86m | 18.70m | -- | -- | 10.02 | -- | 3,962.48 | -0.0318 | -0.0318 | 0.00005 | 0.012 | 0.002 | -- | 0.0104 | -- | -124.17 | -- | -173.37 | -- | -- | -- | -60,684.75 | -- | -- | -544.58 | 0.2174 | -- | -57.45 | -- | -1.20 | -- | -- | -- |
